Patents by Inventor Rodolfo F. PERINI

Rodolfo F. PERINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER
    Publication number: 20180185483
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Listeria based strain that expresses prostate-tissue specific antigen (PSA), and the use of the combination therapies for the treatment of prostate cancer.
    Type: Application
    Filed: January 9, 2018
    Publication date: July 5, 2018
    Inventors: Robert PETIT, David J. MAURO, Rodolfo F. PERINI
  • Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer
    Patent number: 9907849
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Listeria based strain that expresses prostate-tissue specific antigen (PSA), and the use of the combination therapies for the treatment of prostate cancer.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: March 6, 2018
    Assignees: Advaxis, Inc., Merck Sharp & Dohme Corp.
    Inventors: Robert Petit, David J. Mauro, Rodolfo F. Perini
  • TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR
    Publication number: 20160303231
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and VEGFR inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.
    Type: Application
    Filed: December 3, 2014
    Publication date: October 20, 2016
    Inventors: Robert Iannone, Rodolfo F. Perini, Joseph H. Phillips, Sriram Venkataraman, Elaine Marie Paul
  • COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER
    Publication number: 20160022814
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Listeria based strain that expresses prostate-tissue specific antigen (PSA), and the use of the combination therapies for the treatment of prostate cancer.
    Type: Application
    Filed: July 17, 2015
    Publication date: January 28, 2016
    Inventors: Robert PETIT, David J. MAURO, Rodolfo F. PERINI